IDNA iShares Genomics Immunology and Healthcare ETF

Seeks to track, before fees and expenses, the NYSE FactSet Global Genomics and Immuno Biopharma Index. The Index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.

$28.29  -0.33 (-1.15%)
As of 05/16/2022 16:00:00 EST     IEX book   CBOE book

---

ETF Information

---

Sponsor:     iShares
Category1:  Global Equity
Category2:  Single industry
Category3:  Healthcare
Morningstar category:  
Leverage factor:  1.00
Inception date:  06/13/2019
Index tracking method: Passive replication
Current yield:  1.08%
Historical average yield:  0.59%
Market cap:  $179,470,000
Average volume:  70,177
Fees:     0.4700%

---

Index Information

---

NYSE FactSet Global Genomics and Immuno Biopharma Index
Index symbol:  NYFSGIBN
Provider:   ICE (NYSE)
Index weighting:   Market capitalization
Index inception date:  01/01/1900
Backtesting data exists:  
Number of holdings:  48  (as of 01/20/2020)